Hongchao Pan

MSc PhD

Associate Professor, CTSU

Hongchao Pan is a statistician and epidemiologist in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU). He holds a PhD in astrophysics from University of Leicester and an MSc in epidemiology from London School of Hygiene & Tropical Medicine. Since joining CTSU in 1995, he has worked on number of large-scale randomised clinical trials (such as CAST, COMMIT/CCS2, ACST, ATLAS) and epidemiological studies.

His research interests include systemic treatments for early breast cancer, effect of obesity on breast cancer prognosis, and mortality from smoking. Dr Pan leads the meta-analysis of individual participant data of the breast cancer screening trials with mammography and the long-term follow-up of the British Doctors Study.

Recent publications

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Journal article

WHO Solidarity Trial Consortium None. et al, (2020), N Engl J Med
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
Journal article

PAN H. and Peto R., (2020), MedRxiv
Smoking and risk of Parkinson's disease: 65 year follow-up of the British Doctors study
Journal article

CLARKE R. et al, (2020), Neurology
Timing of procedural stroke and death in asymptomatic patients undergoing carotid endarterectomy: analysis of VACS, ACAS, ACST-1 and GALA RCTs
Journal article

Poorthuis M. et al, (2019), British Journal of Surgery
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Journal article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39